AML patients benefit from stem cell transplants
Tuesday, June 9, 2009 - 15:21
in Health & Medicine
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.read more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Study IDs benefit of donor SCT for adults with acute myeloid leukemiaTue, 9 Jun 2009, 16:45:12 EDT
- Donor stem cell transplantation associated with survival benefit for patients with leukemiaTue, 9 Jun 2009, 16:45:18 EDT
- Increasing the number of kidney transplantsThu, 20 Aug 2009, 17:22:29 EDT
- Leukemia stem cells have more in common with embryonic stem cells than adult stem cellsThu, 5 Feb 2009, 12:45:38 EST
- First use of antibody and stem cell transplantation to successfully treat advanced leukemiaThu, 5 Nov 2009, 12:38:55 EST